Inhibition of proteolytic enzymes by serum of normal persons and patients with various diseases has been the subject of numerous investigations since Camus and Gley in 1897 (1) first observed that normal serum markedly inhibits the activity of trypsin. Serum proteolytic inhibition was found to be increased in association with many diseases. Jobling and Petersen presented a comprehensive review of the subject in 1914 (2), and Grob reviewed the interval literature in 1942 (3). The physiological significance of proteolytic inhibition and the reasons for its increase with disease are not yet known. Trypsin has been the enzyme usually employed in studying proteolytic inhibition by serum. More recently there has been interest in the inhibition of other proteolytic enzymes, e.g., plasmin (4, 5) and chymotrypsin (6).The detailed mechanisms by means of which serum inhibits proteolytic enzymes have received relatively little attention. Using gelatin as a substrate, Hussey and Northrop in 1922 (7) studied the inhibition of trypsin by plasma and obtained results indicating that the inhibition was a stoichiometric, readily reversible reaction. Using casein as substrate, Grob in 1942 (3) studied the inhibition of trypsin by serum and came to a similar conclusion. The mechanism of the inhibition of plasmin and chymotrypsin by serum has not been studied.The present work is concerned with comparing the mechanisms of the inhibition of trypsin, plasmin, and chymotrypsin by serum using fibrin tagged with radioactive iodine as a substrate. The effect of relative concentrations of enzyme and inhibitor on the enzyme-inhibitor relationship, and also the effect of substrate concentration on inhibition were studied.In subsequent papers the findings obtained here are applied in the demon-* This work was done during the tenure of a Damon Runyon Clinical Research Fellowship.